| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.39 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.31 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.35 | 0.03 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |